Prospective, Randomized Comparison of Intravenous and Oral Ciprofloxacin with Intravenous Ceftazidime in the Treatment of Nosocomial Pneumonia

OBJECTIVE: To compare the efficacy of intravenous and oral ciprofloxacin and intravenous ceftazidime in the treatment of nosocomial pneumonia.

Saved in:
Bibliographic Details
Main Authors: Raphael Saginur, Gary Garber, Gail Darling, Stephen Shafran, William Cameron, Gwynne Jones, Francois Auclair, the Canadian Infectious Disease Society Multicenter Nosocomial Pneumonia Study Group
Format: Article
Language:English
Published: Wiley 1997-01-01
Series:Canadian Journal of Infectious Diseases
Online Access:http://dx.doi.org/10.1155/1997/973029
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558735719923712
author Raphael Saginur
Gary Garber
Gail Darling
Stephen Shafran
William Cameron
Gwynne Jones
Francois Auclair
the Canadian Infectious Disease Society Multicenter Nosocomial Pneumonia Study Group
author_facet Raphael Saginur
Gary Garber
Gail Darling
Stephen Shafran
William Cameron
Gwynne Jones
Francois Auclair
the Canadian Infectious Disease Society Multicenter Nosocomial Pneumonia Study Group
author_sort Raphael Saginur
collection DOAJ
description OBJECTIVE: To compare the efficacy of intravenous and oral ciprofloxacin and intravenous ceftazidime in the treatment of nosocomial pneumonia.
format Article
id doaj-art-81ff92e3470d4f8a93e1e5d801a193fc
institution Kabale University
issn 1180-2332
language English
publishDate 1997-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases
spelling doaj-art-81ff92e3470d4f8a93e1e5d801a193fc2025-02-03T01:31:39ZengWileyCanadian Journal of Infectious Diseases1180-23321997-01-0182899410.1155/1997/973029Prospective, Randomized Comparison of Intravenous and Oral Ciprofloxacin with Intravenous Ceftazidime in the Treatment of Nosocomial PneumoniaRaphael Saginur0Gary Garber1Gail Darling2Stephen Shafran3William Cameron4Gwynne Jones5Francois Auclair6the Canadian Infectious Disease Society Multicenter Nosocomial Pneumonia Study GroupDepartment of Medicine, Ottawa Civic Hospital, CanadaUniversity of Ottawa, Ottawa, Ontario, CanadaDepartment of Surgery, Wellesley Hospital and University of Toronto, Toronto, Ontario, CanadaDepartment of Medicine, University of Alberta Hospitals, CanadaDepartment of Medicine, Ottawa General Hospital, CanadaDepartment of Medicine, Ottawa General Hospital, CanadaUniversity of Ottawa, Ottawa, Ontario, CanadaOBJECTIVE: To compare the efficacy of intravenous and oral ciprofloxacin and intravenous ceftazidime in the treatment of nosocomial pneumonia.http://dx.doi.org/10.1155/1997/973029
spellingShingle Raphael Saginur
Gary Garber
Gail Darling
Stephen Shafran
William Cameron
Gwynne Jones
Francois Auclair
the Canadian Infectious Disease Society Multicenter Nosocomial Pneumonia Study Group
Prospective, Randomized Comparison of Intravenous and Oral Ciprofloxacin with Intravenous Ceftazidime in the Treatment of Nosocomial Pneumonia
Canadian Journal of Infectious Diseases
title Prospective, Randomized Comparison of Intravenous and Oral Ciprofloxacin with Intravenous Ceftazidime in the Treatment of Nosocomial Pneumonia
title_full Prospective, Randomized Comparison of Intravenous and Oral Ciprofloxacin with Intravenous Ceftazidime in the Treatment of Nosocomial Pneumonia
title_fullStr Prospective, Randomized Comparison of Intravenous and Oral Ciprofloxacin with Intravenous Ceftazidime in the Treatment of Nosocomial Pneumonia
title_full_unstemmed Prospective, Randomized Comparison of Intravenous and Oral Ciprofloxacin with Intravenous Ceftazidime in the Treatment of Nosocomial Pneumonia
title_short Prospective, Randomized Comparison of Intravenous and Oral Ciprofloxacin with Intravenous Ceftazidime in the Treatment of Nosocomial Pneumonia
title_sort prospective randomized comparison of intravenous and oral ciprofloxacin with intravenous ceftazidime in the treatment of nosocomial pneumonia
url http://dx.doi.org/10.1155/1997/973029
work_keys_str_mv AT raphaelsaginur prospectiverandomizedcomparisonofintravenousandoralciprofloxacinwithintravenousceftazidimeinthetreatmentofnosocomialpneumonia
AT garygarber prospectiverandomizedcomparisonofintravenousandoralciprofloxacinwithintravenousceftazidimeinthetreatmentofnosocomialpneumonia
AT gaildarling prospectiverandomizedcomparisonofintravenousandoralciprofloxacinwithintravenousceftazidimeinthetreatmentofnosocomialpneumonia
AT stephenshafran prospectiverandomizedcomparisonofintravenousandoralciprofloxacinwithintravenousceftazidimeinthetreatmentofnosocomialpneumonia
AT williamcameron prospectiverandomizedcomparisonofintravenousandoralciprofloxacinwithintravenousceftazidimeinthetreatmentofnosocomialpneumonia
AT gwynnejones prospectiverandomizedcomparisonofintravenousandoralciprofloxacinwithintravenousceftazidimeinthetreatmentofnosocomialpneumonia
AT francoisauclair prospectiverandomizedcomparisonofintravenousandoralciprofloxacinwithintravenousceftazidimeinthetreatmentofnosocomialpneumonia
AT thecanadianinfectiousdiseasesocietymulticenternosocomialpneumoniastudygroup prospectiverandomizedcomparisonofintravenousandoralciprofloxacinwithintravenousceftazidimeinthetreatmentofnosocomialpneumonia